Sign in
AWH Stock Price, Chart, Stats & News
Aspira Women's Health Inc.
Save
2.46M
Market cap
–
Current P/E
–
Forward P/E
AWH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.90% |
Operating margin | -107.74% |
Pretax margin | -115.66% |
Net margin | -115.66% |
Effective tax rate | – |
ROA | -148.01% |
ROE | 447.53% |
D/E | -0.59x |
Interest coverage ratio | 773.85x |
AWH valuation
P/E | – |
P/S | 0.26x |
P/B | -0.69x |
P/CF | -0.49x |
P/FCF | -0.40x |
P/OCF | -0.49x |
PEG | -0.25x |
EV multiple | -0.31x |
About
Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses. Additionally, they provide ASPiRA GenetiX, a genetic screening option for assessing individual susceptibility to gynecologic cancers.
Similar securities
Based on sector and market capitalization
Report issue